Wells Fargo’s X4 Pharmaceuticals XFOR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$661 Sell
348
-2,370
-87% -$4.5K ﹤0.01% 5889
2025
Q1
$19.3K Buy
2,718
+101
+4% +$716 ﹤0.01% 5267
2024
Q4
$57.6K Buy
2,617
+892
+52% +$19.6K ﹤0.01% 4941
2024
Q3
$34.6K Sell
1,725
-68
-4% -$1.37K ﹤0.01% 5079
2024
Q2
$31.2K Buy
1,793
+428
+31% +$7.45K ﹤0.01% 5084
2024
Q1
$56.9K Buy
1,365
+198
+17% +$8.26K ﹤0.01% 4828
2023
Q4
$29.4K Buy
1,167
+246
+27% +$6.19K ﹤0.01% 5058
2023
Q3
$30.1K Sell
921
-714
-44% -$23.3K ﹤0.01% 5071
2023
Q2
$95.2K Buy
1,635
+1,610
+6,440% +$93.7K ﹤0.01% 4805
2023
Q1
$655 Buy
25
+11
+79% +$288 ﹤0.01% 6164
2022
Q4
$424 Sell
14
-5
-26% -$151 ﹤0.01% 6101
2022
Q3
$1K Buy
19
+13
+217% +$684 ﹤0.01% 6152
2022
Q2
$0 Buy
6
+1
+20% ﹤0.01% 7255
2022
Q1
$0 Buy
5
+1
+25% ﹤0.01% 7317
2021
Q4
$0 Hold
4
﹤0.01% 7300
2021
Q3
$1K Hold
4
﹤0.01% 6477
2021
Q2
$1K Sell
4
-182
-98% -$45.5K ﹤0.01% 6412
2021
Q1
$48K Sell
186
-719
-79% -$186K ﹤0.01% 5478
2020
Q4
$174K Buy
905
+464
+105% +$89.2K ﹤0.01% 5000
2020
Q3
$89K Sell
441
-140
-24% -$28.3K ﹤0.01% 5109
2020
Q2
$163K Sell
581
-224
-28% -$62.8K ﹤0.01% 4838
2020
Q1
$242K Buy
805
+21
+3% +$6.31K ﹤0.01% 4406
2019
Q4
$252K Buy
784
+19
+2% +$6.11K ﹤0.01% 4680
2019
Q3
$292K Buy
765
+387
+102% +$148K ﹤0.01% 4586
2019
Q2
$170K Buy
378
+363
+2,420% +$163K ﹤0.01% 4868
2019
Q1
$8K Hold
15
﹤0.01% 5556
2018
Q4
$6K Hold
15
﹤0.01% 5643
2018
Q3
$4K Buy
15
+1
+7% +$267 ﹤0.01% 5723
2018
Q2
$9K Sell
14
-1
-7% -$643 ﹤0.01% 5626
2018
Q1
$60K Buy
+15
New +$60K ﹤0.01% 5228